Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Opportunistic Infections »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ophthalmoscopy < Opportunistic Infections < Opsonin Proteins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]
Ident.Authors (with country if any)Title
000253 (2019) Lianne Kearsley-Fleet [Royaume-Uni] ; Sunil Sampath [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.
000349 (2019) Ajinkya Pawar [États-Unis] ; Rishi J. Desai [États-Unis] ; Daniel H. Solomon [États-Unis] ; Adrian J. Santiago Ortiz [États-Unis] ; Sara Gale [États-Unis] ; Min Bao [États-Unis] ; Khaled Sarsour [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Seoyoung C. Kim [États-Unis]Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.
000381 (2019) Kenan Barut [Turquie] ; Amra Adrovic [Turquie] ; Sezgin Sahin [Turquie] ; Gurkan Tarcin [Turquie] ; Gulberk Tahaoglu [Turquie] ; Oya Koker [Turquie] ; Mehmet Yildiz [Turquie] ; Ozgur Kasapcopur [Turquie]Prognosis, complications and treatment response in systemic juvenile idiopathic arthritis patients: A single-center experience.
000464 (2019) Tomohisa Uchida ; Momoko Okamoto ; Keita Fujikawa ; Daisuke Yoshikawa ; Akinari Mizokami ; Tomo Mihara ; Akira Kondo ; Kazuo Ohba ; Kazuhiro Kurohama ; Masahiro Nakashima ; Ichiro Sekine ; Shigeki Nakamura [Japon] ; Yoshitsugu Miyazaki [Japon] ; Atsushi Kawakami [Japon]Gastric mucormycosis complicated by a gastropleural fistula: A case report and review of the literature.
000702 (2018) Andrew I. Rutherford [Royaume-Uni] ; Sujith Subesinghe [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni] ; James B. Galloway [Royaume-Uni]Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
000903 (2018) Rossella Talotta [Italie] ; Fabiola Atzeni [Italie] ; Alberto Batticciotto [Italie] ; Maurizio Benucci [Italie] ; Sara Bongiovanni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Biological Agents in Rheumatoid Arthritis: A Cross-Link Between Immune Tolerance and Immune Surveillance.
000A76 (2017) Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France]Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.
000B72 (2017) Robert J. Moots [Royaume-Uni] ; Anthony Sebba [États-Unis] ; William Rigby [États-Unis] ; Andrew Ostor ; Benjamin Porter-Brown [Royaume-Uni] ; Francis Donaldson [Royaume-Uni] ; Sophie Dimonaco [Royaume-Uni] ; Andrea Rubbert-Roth [Allemagne] ; Ronald Van Vollenhoven [Suède] ; Mark C. Genovese [États-Unis]Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials.
000C65 (2016) W. Opstelten [Pays-Bas] ; J W J. Bijlsma ; L B S. Gelinck ; C M J. Hielkema ; Th J M. Verheij ; W. Van Eden[Impaired immunity: risk groups and consequences for general practice].
000D73 (2016) Christof Iking-Konert [Allemagne] ; Ulrich Von Hinüber [Allemagne] ; Constanze Richter [Allemagne] ; Holger Schwenke [Allemagne] ; Irmgard Gürtler [Allemagne] ; Peter K Stner [Allemagne] ; Birgit Klapperich [Suisse] ; Marvin A. Peters ; Gerd-Rüdiger Burmester [Allemagne]ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in Germany.
000F24 (2016) Sulaiman M. Al-Mayouf [Arabie saoudite] ; Abdullatif Alenazi [Arabie saoudite] ; Hind Aljasser [Arabie saoudite]Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.
001034 (2015) Huifeng Yun ; Fenglong Xie ; Elizabeth Delzell ; Lang Chen ; Emily B. Levitan ; James D. Lewis ; Kenneth G. Saag ; Timothy Beukelman ; Kevin Winthrop ; John W. Baddley ; Jeffrey R. CurtisRisks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.
001059 (2015) Maarit Tarkiainen [Finlande] ; Pirjo Tynj L [Finlande] ; Paula V H Salo [Finlande] ; Pekka Lahdenne [Finlande]Occurrence of adverse events in patients with JIA receiving biologic agents: long-term follow-up in a real-life setting.
001062 (2015) Daisuke Kobayashi [Japon] ; Satoshi Ito ; Akira Hirata ; Asami Abe ; Akira Murasawa ; Ichiei Narita ; Kiyoshi NakazonoMycobacterium abscessus Pulmonary Infection under Treatment with Tocilizumab.
001076 (2015) Michaela Cellina [Italie] ; Vincenza Fetoni ; Pierluigi Baron ; Marcello Orsi ; Giancarlo OlivaListeria Meningoencephalitis in a Patient With Rheumatoid Arthritis on Anti-Interleukin 6 Receptor Antibody Tocilizumab.
001291 (2014) Sofia Ramiro [Pays-Bas] ; Cécile Gaujoux-Viala ; Jackie L. Nam ; Josef S. Smolen ; Maya Buch ; Laure Gossec ; Désirée Van Der Heijde ; Kevin Winthrop ; Robert LandewéSafety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.
001309 (2014) Hiroki Wakabayashi [Japon] ; Shinya Takigawa [Japon] ; Masahiro Hasegawa [Japon] ; Takuya Kakimoto [Japon] ; Kakunoshin Yoshida [Japon] ; Akihiro Sudo [Japon]Polyarticular late infection of total joint arthroplasties in a patient with rheumatoid arthritis treated with anti-interleukin-6 therapy.
001569 (2013) Daniel Wendling ; Sylvère Hugonnot ; Florent Montini ; Clément PratiInfluenza H1N1 infection in a patient with rheumatoid arthritis treated with tocilizumab.
001623 (2013) Morgane Milin [France] ; Marie Acquitter ; Rozenn Le Berre ; Bruno Sassolas ; Valérie Devauchelle-Pensec ; Divi CornecBartonella henselae infection during tocilizumab therapy.
001735 (2012) Eric M. Ruderman [États-Unis]Overview of safety of non-biologic and biologic DMARDs.
001761 (2012) Jatinder P. Ahluwalia [États-Unis]Immunotherapy in inflammatory bowel disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Opportunistic Infections" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Opportunistic Infections" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Opportunistic Infections
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021